Fact CheckerSign in

NCT07837856Completed

Therapeutic Adherence in Type 2 Diabetes

WhatsApp Messaging Versus SMART Goal-setting to Improve Therapeutic Adherence in Patients With Type 2 Diabetes in Primary Care: a Quasi-experimental Study

Source: ClinicalTrials.gov · Last updated 24 Sept 2026

Brief summary (registry, in English)

A quasi-experimental, non-randomized, prospective, longitudinal study comparing the use of WhatsApp messaging versus the SMART technique in patients with type 2 diabetes to improve treatment adherence

Status (registry)
Completed
Study type
Interventional
Enrollment
250 (actual)
First submitted
10 Sept 2026
Start date
30 Nov 2024
Primary completion date
30 Dec 2025
Lead sponsor
Instituto Mexicano del Seguro Social
NCT number
NCT07837856

What you commit to

  • Study type: Interventional
  • Participants enrolled: 250
  • From 30 Nov 2024 to the primary completion date, 30 Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • • Patients with type 1 diabetes mellitus.
    • Patients with dementia, schizophrenia, alcoholism, drug addiction, cancer, Parkinson's disease, hearing and vision impairments, and comprehension and language disorders.
    • Pregnant patients.
    • Patients who cannot read or write.

Lab values

  • Patients who fail to attend laboratory tests, questionnaire administration, or regular medical appointments.

Other

  • Patients who withdraw their consent.
  • Patient death.
  • Changes in health insurance enrollment.
  • Loss of health insurance coverage.

Who the study is looking for

  • • Patients with type 2 diabetes mellitus.
    • Patients enrolled in UMF 84.
    • Men and women between the ages of 35 and 70.
    • Patients who agree to participate, understand the informed consent form, and sign it.
    • Patients who have a cell phone and the WhatsApp app.

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Family Medicine Unit No. 84
Coordinator of this site? Confirm its status
MoreliaMexicoUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.